Search results
Showing results for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Journal article
Monk V. et al, (2026), Expert Rev Vaccines, 25
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Journal article
Firth C. et al, (2026), Hum Vaccin Immunother, 22
COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)
Journal article
Pokhrel B. et al, (2026), Vaccine: X, 31, 100864 - 100864
Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.
Journal article
Kelleher K. et al, (2026), BMJ Open, 16
Serological thresholds of risk reduction for infant group B streptococcus disease
Preprint
Cantrell L. et al, (2026)
In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.
Journal article
Reiné J. et al, (2026), Comput Biol Chem, 122
Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.
Journal article
Hesari E. et al, (2026), J Diabetes Metab Disord, 25
Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and Patients With Tuberculosis: An Observational Case-Control Study.
Journal article
Rongkard P. et al, (2026), Open Forum Infect Dis, 13
Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.
Journal article
Alsaleh G. et al, (2026), Aging Cell, 25
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.
Journal article
Reiné J. et al, (2026), Cell Rep, 45
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.
Journal article
Hagedoorn NN. et al, (2026), Vaccine, 85
Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.
Journal article
Hysa A. et al, (2026), PLoS Med, 23
National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan.
Journal article
Abu Lubad M. et al, (2026), Pathogens, 15
The human immune response to viral vectored vaccine regimens against Ebola virus and Sudan virus in clinical trials
Thesis / Dissertation
Makinson R., (2026)
The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.
Journal article
Stuart AS. et al, (2026), BMC Public Health
Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.
Journal article
Dahal A. et al, (2026), BMJ Glob Health, 11
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.
Journal article
Thorn N. et al, (2026), Lancet Infect Dis
Predicting trajectories of illness using RNA velocity of whole blood.
Journal article
Dunican C. et al, (2026), Nat Commun, 17
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.
Journal article
Chirwa AE. et al, (2026), Lancet Microbe, 7
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Journal article
GBD 2023 Meningitis & Antimicrobial Resistance Collaborators ., (2026), Lancet Neurol, 25, 451 - 468

